US Stock MarketDetailed Quotes

NRXP NRX Pharmaceuticals

Watchlist
  • 4.0100
  • -0.2500-5.87%
Close Jan 17 16:00 ET
  • 3.9600
  • -0.0500-1.25%
Post 20:01 ET
48.50MMarket Cap-1.90P/E (TTM)

About NRX Pharmaceuticals Company

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.

Company Profile

SymbolNRXP
Company NameNRX Pharmaceuticals
Listing DateDec 1, 2017
Founded2017
CEODr. Jonathan C. Javitt,M.D.,M.P.H.
MarketNASDAQ
Fiscal Year Ends12-31
Address1201 Orange Street,Suite 600
CityWilmington
ProvinceDelaware
CountryUnited States of America
Zip Code19801
Phone1-484-254-6134
Websitehttp://www.nrxpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jonathan C. Javitt,M.D.,M.P.H.
  • Chairman of the Board, Chief Scientist and Interim Chief Executive Officer
  • 630.20K
  • Michael S. Abrams
  • Chief Financial Officer
  • --
  • Matthew Duffy
  • Chief Business Officer
  • --
  • Dr. Riccardo Panicucci, PhD
  • Chief Manufacturing and Technology Officer and Technical Operations Advisor
  • --
  • Dr. Dennis McBride, PhD
  • Director
  • --
  • Patrick J. Flynn
  • Independent Director
  • 67.50K
  • Chaim Hurvitz
  • Independent Director
  • 52.50K
Heat List
US
Overall
Symbol
Price
% Chg

No Data